ConductScience.org, home

Paper30622011

Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.

Burmaoglu S and 5 others. Bioorg Chem, 2019. Cited by 97 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors. Papers, record 30622011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30622011

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
PubMed
Journal
Bioorg Chem
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
7.42
iCite
Revised in PubMed
2026-01-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burmaoglu SSerdar
2Yilmaz AOAli Osman
3Polat MFM Fatih
4Kaya RRüya
5Gulcin İİlhami
6Algul OOztekin

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carbonic Anhydrase InhibitorsMajor topic
ChalconesMajor topic
Cholinesterase InhibitorsMajor topic
Glycoside Hydrolase InhibitorsMajor topic
Acetylcholinesterase
Butyrylcholinesterase
Carbonic Anhydrase I
Carbonic Anhydrase II
Humans
Molecular Structure
Carrier Proteins
Nerve Tissue Proteins

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
42133206Integrated computational modeling of chalcone-based inhibitors targeting carbonic anhydrase I and II: 3D-QSAR, molecular docking, and dynamics simulations.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42133206PubMed
41726615Activity-Selectivity of Flavonoid Derivatives in Endometriotic Cells.ACS Omega2026https://conductscience.org/library/papers/41726615PubMed
40232392Antioxidants: a comprehensive review.Arch Toxicol2025https://conductscience.org/library/papers/40232392PubMed
40126739Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer's disease treatment.Mol Divers2025https://conductscience.org/library/papers/40126739PubMed
38283214Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies.RSC Med Chem2024https://conductscience.org/library/papers/38283214PubMed
38170420Organohalogen chalcones: design, synthesis, ADMET prediction, molecular dynamics study and inhibition effect on acetylcholinesterase and carbonic anhydrase.Mol Divers2024https://conductscience.org/library/papers/38170420PubMed
37396160Antihyperglycemic and anti-type 2 diabetic activity of marine hydroquinone isolated from brown algae (Dictyopteris polypodioides).J Tradit Complement Med2023https://conductscience.org/library/papers/37396160PubMed
37190818A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors.CNS Neurol Disord Drug Targets2024https://conductscience.org/library/papers/37190818PubMed
37110646Naturally Occurring Chalcones with Aggregation-Induced Emission Enhancement Characteristics.Molecules2023https://conductscience.org/library/papers/37110646PubMed
36986640Synthesis of Schiff Bases Containing Phenol Rings and Investigation of Their Antioxidant Capacity, Anticholinesterase, Butyrylcholinesterase, and Carbonic Anhydrase Inhibition Properties.Pharmaceutics2023https://conductscience.org/library/papers/36986640PubMed
36838726Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects.Molecules2023https://conductscience.org/library/papers/36838726PubMed
36655459Experimental Approaches to Diabetes Mellitus.Eurasian J Med2022https://conductscience.org/library/papers/36655459PubMed
36561337Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor.Front Pharmacol2022https://conductscience.org/library/papers/36561337PubMed
36508118Acetylphenyl-substituted imidazolium salts: synthesis, characterization, in silico studies and inhibitory properties against some metabolic enzymes.Mol Divers2023https://conductscience.org/library/papers/36508118PubMed
36364255Synthesis of Novel Bromophenol with Diaryl Methanes-Determination of Their Inhibition Effects on Carbonic Anhydrase and Acetylcholinesterase.Molecules2022https://conductscience.org/library/papers/36364255PubMed
36296499Sahlep (Dactylorhiza osmanica): Phytochemical Analyses by LC-HRMS, Molecular Docking, Antioxidant Activity, and Enzyme Inhibition Profiles.Molecules2022https://conductscience.org/library/papers/36296499PubMed
36185151The palladium-based complexes bearing 1,3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: synthesis, characterization, structure and enzyme inhibitions.Heliyon2022https://conductscience.org/library/papers/36185151PubMed
36105949Heterocyclic compounds as a magic bullet for diabetes mellitus: a review.RSC Adv2022https://conductscience.org/library/papers/36105949PubMed
35630658Chalcone Scaffolds Exhibiting Acetylcholinesterase Enzyme Inhibition: Mechanistic and Computational Investigations.Molecules2022https://conductscience.org/library/papers/35630658PubMed
35328542Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.Int J Mol Sci2022https://conductscience.org/library/papers/35328542PubMed

See all 31 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
CA1759PubTator's text mininghttps://conductscience.org/library/genes/759NCBI Gene
CA2760PubTator's text mininghttps://conductscience.org/library/genes/760NCBI Gene
CYP24A11591PubTator's text mininghttps://conductscience.org/library/genes/1591NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30622011

GET https://conductscience.org/api/papers/v1/30622011/cited_by?page=2